Bupropion Tablets 12hr SA Tablets   3

Background
The Department of Veterans Affairs (VA) is issuing this solicitation to establish a supply source for pharmaceutical products through its Pharmaceutical Prime Vendor (PPV) Programs. The goal is to ensure availability and consistency of products for nationwide usage while obtaining volume-based pricing. This contract will provide drugs listed in the schedule for purchase through the PPV Programs, which include various government health facilities.

Work Details
The contract involves the supply of Bupropion Hydrochloride (HCL) 12-hour Sustained Action (SA) Tablets in various formulations and quantities. The specific line items are as follows:

1. **BUPROPION HCL 100MG 12HR SA TABLETS (60 TABLETS per BOTTLE)**
- Quantity: 77,795 bottles for Base Year
- Package Size: 60 tablets per bottle

2. **BUPROPION HCL 100MG 12HR SA TABLETS (500 TABLETS per BOTTLE)**
- Quantity: 20,289 bottles for Base Year
- Package Size: 500 tablets per bottle

3. **BUPROPION HCL 150MG 12HR SA TABLETS (60 TABLETS per BOTTLE)**
- Quantity: 158,669 bottles for Base Year
- Package Size: 60 tablets per bottle

4. **BUPROPION HCL 150MG 12HR SA TABLETS (500 TABLETS per BOTTLE)**
- Quantity: 36,203 bottles for Base Year
- Package Size: 500 tablets per bottle

5. **BUPROPION HCL 200MG 12HR SA TABLETS (60 TABLETS per BOTTLE)**
- Quantity: 73,742 bottles for Base Year
- Package Size: 60 tablets per bottle.
Each line item requires an offeror to submit a price for the base year and all four one-year options, including a unique National Drug Code (NDC) number and adherence to specific packaging requirements.

Period of Performance
The contract will be effective upon signing and notification of award, with an implementation period allowing up to a maximum of 60 days before the ordering period begins.

Place of Performance
Products will be delivered to various locations as specified by the VA and DoD Pharmaceutical Prime Vendor Programs.